Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An anaplastic large cell lymphoma that affects the brain, meninges, or spinal cord.
Biomarker and diagnostic research for central nervous system anaplastic large cell lymphoma has been reported in the published literature.
No clinical trials have been registered for central nervous system anaplastic large cell lymphoma.
23 publications have been identified in PubMed for central nervous system anaplastic large cell lymphoma. Research spans Case Report / Case Series (57%), Diagnostic / Biomarker (10%), and Review / Meta-Analysis (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 57% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:51 AM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
Testing and diagnosis research |
2 |
10% |
Research summaries | 2 | 10% |
Clinical study results | 2 | 10% |
Other research | 1 | 5% |
Laboratory research | 1 | 5% |
Disease patterns and progression | 1 | 5% |
Ju W (2026). [PMID: 41619778](https://pubmed.ncbi.nlm.nih.gov/41619778/). *Br J Neurosurg*. [Case Report / Case Series]
Knörr F (2026). [PMID: 41632689](https://pubmed.ncbi.nlm.nih.gov/41632689/). *Blood Adv*. [Clinical Trial Publication]
Hao Z (2026). [PMID: 41959915](https://pubmed.ncbi.nlm.nih.gov/41959915/). *Front Oncol*. [Case Report / Case Series]
Chen Y (2026). [PMID: 41509524](https://pubmed.ncbi.nlm.nih.gov/41509524/). *BMJ Neurol Open*. [Review / Meta-Analysis]
Li J (2025). [PMID: 41183823](https://pubmed.ncbi.nlm.nih.gov/41183823/). *Zhonghua Bing Li Xue Za Zhi*. [Case Report / Case Series]
Weaver AE (2025). [PMID: 40699359](https://pubmed.ncbi.nlm.nih.gov/40699359/). *Childs Nerv Syst*. [Case Report / Case Series]
Ma YT (2025). [PMID: 40613167](https://pubmed.ncbi.nlm.nih.gov/40613167/). *Zhongguo Shi Yan Xue Ye Xue Za Zhi*. [Diagnostic / Biomarker]
Salah A (2025). [PMID: 40444097](https://pubmed.ncbi.nlm.nih.gov/40444097/). *Front Oncol*. [Basic Science / Preclinical]
Zou Z (2025). [PMID: 40777017](https://pubmed.ncbi.nlm.nih.gov/40777017/). *Front Immunol*. [Case Report / Case Series]
Yang X (2025). [PMID: 40702677](https://pubmed.ncbi.nlm.nih.gov/40702677/). *Pediatr Blood Cancer*. [Clinical Trial Publication]
AI-curated news mentioning central nervous system anaplastic large cell lymphoma
Updated Aug 4, 2026
A study highlights the presence of SETD2 mutations in primary central nervous system T cell lymphoma, which affects multiple brain and spinal cord lesions. This discovery may provide insights into the genetic underpinnings of this rare lymphoma subtype.